The upregulated usage of AKT2 isoform in the high‐risk OLGIM group lacked the kinase domain present in the canonical AKT2 isoform, which could indicate that increased levels of the isoform dysregulated signaling pathways, facilitating tumor progression. Here, AKT2 is linked to neoplasm.